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1. Introduction 
Cellulose, a natural polymer, has been widely used in blood purification due to its good 
biocompatibility, and excellent processing which can be easily formulated into beads, 
membranes and hollow fibers. Sorbent-perfusion is a novel approach of blood purification 
which can specifically remove endogenous and exogenous pathogenic toxins from the blood 
of patients [1]. The technique involves passing whole blood or plasma of the patient through 
a cartridge filled with an adsorbent which can easily adsorb the toxin molecules, see Figure 
1 a,b. According to selectivity, generally adsorbents can be classified as broad spectrum, 
affinity adsorbents and immuno-adsorbents, of which the latter has the highest selectivity 
[2-5]. Materials, most commonly used are activated charcoal [6], porous resins and fibers. 
The pathogenic substances in the blood of patients are adsorbed by the adsorbent via 
hydrophilic (electro-static forces) or hydrophobic interactions. Macroporous resins usually 
show high adsorption capacities especially for the removal of high molecular weight or 
“middle molecules” toxins [7-9].  
 
Figure 1. Schematic diagram of sorbent-perfusion 
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2. Preparation and activation of cellulosic beads 
2.1. Preparation of cellulosic beads [10, 11] 
One hundred grams of cotton (medical grade) was soaked in a flask containing 19% NaOH 
solution for 3 h at room temperature. The cotton was squeezed and weighed then placed in 
a 1500 ml conical flask at 25℃ for 3 days. Fifty milliliters of carbon disulfide was added to 
the conical flask which was then sealed and aged for 5 h to convert the cellulose into a 
viscose solution, which was then diluted to 1000 ml with 6% NaOH solution to make a 10% 
viscous solution of cellulose. In a reactor equipped with a stirrer, a mixture of 800 ml 
chlorobenzene, 200 ml carbon tetrachloride and 2.0 g of potassium oleate was stirred for 30 
min at 300 rpm under room temperature. Then 300.0 ml of 10% cellulose viscose solution 
was added to the reactor slowly and continued stirring for 30 min until the liquid particles 
were dispersed uniformly. Thereupon, the temperature was slowly raised to 90℃ and kept 
for 2.5 h, after which it was cooled to room temperature to solidify the liquid particles into 
resin beads. Cellulosic beads were filtered (20–40 mesh) and washed thoroughly with 
alcohol and distilled water to remove all the impurities. 
Compared to the gel type cellulosic beads, macroporous beads can greatly enhance the 
adsorption capacity for middle and high molecules in the therapeutic embolization of 
meningiomas [12-15]. It can be synthesized according to reference [16, 17]. In brief, a certain 
amount of pore-forming agent such as calcium carbonate granules, with an average 
diameter of about 0.2mm was added to a 10% viscous solution of cellulose, then mixed and 
dispersed to form cellulosic beads. After washing with dilute HCl to remove the pore-
forming agent, various kinds of porous adsorbents could be prepared. Alternatively, 
macroporous cellulose beads could also be prepared from cellulose solution in ionic liquid 
by double emulsification [18, 19]. 
Recently, cellulosic microspheres with a particle size below 5μm have been widely adopted 
in blood purification [20, 21], which can be an excellent matrix for the preparation of 
adsorbent. 
Bead porosity and density are calculated by the following equations: [10, 17] 
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where P stands for porosity percentage; rs stands for skeleton density; Q stands for water 
content; ρH2O stands for density of water; wtw stands for weight of wet beads; wtd stands for 
weight of dried beads; Vw stands for volume of wet beads; Dp stands for packing density. 
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Adsorption percentage and capacity can be calculated by the following equations, 
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Where AP and AC stand for adsorption percentage and adsorption capacity respectively; 
[C]B is the concentration before adsorption, [C]A is the concentration after adsorption, VP is 
the volume of plasma used during adsorption. 
2.2. Activation of cellulose beads 
Cellulose can be easily activated by reaction with epichlorohydrin which is frequently used 
for the preparation of cellulosic adsorbent [10,22,23].Briefly, 10 grams of cellulosic beads 
was activated with 10ml epichlorohydrin in 20ml 2mol/l sodium hydroxide solution. The 
mixture was stirred at 40℃ for 4 h. Then the epoxy-activated cellulosic beads was washed 
thoroughly with distilled water and further reacted with amino acids or proteins, see Figure 
2. The concentration of sodium hydroxide solution used in the condensation reaction plays 
an important role on the amount of activated expoxy groups linked onto cellulose. This is 
attributed to the condensation and ring opening reaction of epichlorohydrin molecule that 
competes in the reactions, see Figure 3. 
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Figure 2. Activation reaction of cellulosic beads  
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Figure 3. Amount of epoxy groups on cellulose versus concentration of NaOH 
3. Mechanism study of molecular recognition between the ligand and the 
pathogenic toxic molecule. 
3.1. Molecular recognition 
To understand the interaction mechanism of pathogenic toxins with different ligands is 
essential, since it not only provides fundamental insight to biomaterial science, but also can 
lead to the discovery of more efficient ligands for the removal of pathogenic toxins in 
human blood. Chemical modification of proteins has been frequently used in the studies of 
structure-function relationships of proteins, especially in the determination of the active 
sites in biologically active proteins [23,24]. In the present study, we selectively modified the 
arginine, tryptophan, lysine residues and carboxyl terminus on the protein for the molecular 
recognition studies. 
Lianyong Wang et al [25] investigated the interaction between ss- DNA and IgGRF by 
selectively modification of the arginine, tryptophan, lysine residues and carboxyl terminus 
on IgGRF, which was purified from patients’ serum. It is well known that the density of 
negative charge is high on the surface of ss-DNA molecule, due to the large amount of 
phosphate groups. After the ss-DNA was covalently attached to the cellulose carrier, the 
immunoadsorbent is negatively charged, so it has a high adsorption capacity for the 
positively charged N-bromosuccinimide (NBS) modified IgGRF. The same situation 
occurred when N-Ethyl-N’-[3-(dimethylamino)propyl]carbodiimide( EDC) modified IgGRF 
because of its decrease in negatively charged density. The low adsorption capacity for 1，2-
cyclohexanedion（CHD） and pyridoxal 5-phosphate (PP) modified IgGRF may be 
attributed to the reduction of positively charged density after modification. From all the 
experimental results, it is assumed that there is an ionic bond formed between the modified 
IgGRF and the ss-DNA immobilized immunoadsorbent.  
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Shenqi Wang and Yaoting Yu et al [24] studied the mechanism of recognition and 
interactions of low density lipoprotein cholesterol（LDL-C） with different charged ligands 
on the adsorbents. Tryptophan, lysine residues and carboxyl terminus on LDL were 
chemically modified by PP，EDC and NBS respectively. Due to the effectiveness of L-lysine 
in the removal of LDL-C, it was selected to study the interaction of ligand with the modified 
LDL. Experimental results show that positive charge on the surface of LDL interacted with 
the negatively charged carboxyl groups of L-lysine by electrostatic force, thus resulting in 
the adsorption of LDL by the absorbent. We also found that increasing the positive charge 
on the surface of LDL could enhance the adsorption capacity of the adsorbent. On the 
contrary, increasing the negative charge could decrease the adsorption ability. Thus, 
different adsorbents containing sulfonic groups, phosphoric groups, L-lysine and carboxyl 
groups as the ligand were synthesized for investigating the effect of electric charge on their 
adsorption capacity. Results show that the adsorption capacity increases with the increase of 
the electro-negativity of the ligand on the adsorbent. See Table1 
 
Terminus group 
of adsorbent 
TC LDL-C 
Adsorption 
percentage (%) 
Adsorption 
capacity  
(mg /ml) 
Adsorption 
percentage (%) 
Adsorption 
capacity  
(mg/ ml) 
―SO3 2- 52.58 1.998 60.9 1.432 
―PO4 3- 43.86 1.667 44.25 1.039 
PP―PO4 3- 40.39 1.535 39.51 0.928 
DNA―PO43- 34.94 1.328 33.14 0.778 
L-lysine―COO - 31.68 1.203 27.98 0.657 
―COO - 26.02 0.989 13.75 0.323 
Source: Wang S Q et al, Reactive & Functional Polymers (2008), 68: 261-267 
 Adsorption capacity and percentage of total cholesterol(TC), LDL-C by cellulosic beads having Table 1.
different terminus groups 
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(From Wang S Q et al, Reactive & Functional Polymers (2008), 68: 261-267, adapted) 
Figure 4. The relationship of absorption capacity versus electronegativity of ligands immobilized on the 
adsorbent 
 
Cellulose – Medical, Pharmaceutical and Electronic Applications 200 
Experimental results show that the adsorption capacity (mg/ ml or percentage) for TC and 
LDL-C decreased with decreasing of electro-negativity of ligands on the adsorbents  
(－SO32->－PO43->－COO-; －PO43->PP－PO43->DNA－PO43-), which demonstrate that the 
electro-negativity of ligand on adsorbent plays an important role in adsorbing TC and LDL-
C. This relationship of the adsorption capacity to its electro-negativity is shown in Figure. 4 
3.2. Spacer effect 
Spacers have a significant effect on the adsorption property of the resin adsorbents. It can 
reduce the steric hindrance between the ligand and the large toxic molecules, resulting in an 
increase of adsorption capacity of the adsorbent. Different spacers have an obvious effect on 
the adsorption properties of adsorbents. The density of ligands on the carrier and the effect 
of steric hindrance are both important factors in specific adsorption. When the target 
substance is a small molecule, there may be no steric hindrance, see Figure 5 a, so the 
enhancement of the density of ligands can improve the adsorption capacity. But when the 
target substance is a large molecule, due to the presence of steric hindrance [26-33], a high 
density of ligands linked may display a low adsorption capacity of target protein, see Figure 
5b. In theory, a flexible spacers can reduce the steric hindrance, see Figure 5c. In order to 
study flexible spacers play the role in reducing steric hindrance between the target protein 
and immobilized ligands, Xinji Guo et al [34]designed and prepared cellulosic adsorbents 
with L-lysine acid as ligands and PEG having different molecule weights as spacers. 
 
Figure 5. Schematic diagram of interaction between the ligand and target toxins 
Note: a, Interaction between small target molecules and the immobilized ligands; b, Large 
target molecules having a steric hindrance to the immobilized ligands; c, Flexible spacer can 
reduce the steric hindrance, 
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In this study, carboxyl modified PEG spacer was synthesized and linked covalently to 
cellulose beads. L-lysine ligand was coupled to the spacer and its selective affinity for low-
density lipoprotein-cholesterol (LDL-C) was determined. It was found that the adsorption 
capacity and the efficiency of the ligand for adsorption of LDL-C were increased when PEG 
spacer was used. Experimental results showed that by increasing the molecular weight of 
PEG spacers from 1000Da to 6000Da, the average adsorption capacity of LDL-C was 
enhanced from 0.242mg/ml to 0.903mg/ml. According to the analytical data of cellulose 
adsorbents, the amount of L-lysine ligand could be calculated. Although the amount of L-
lysine linked to the adsorbent with PEG spacers (10.5, 9.8, 9.0, 8.6 mg per ml cellulose 
adsorbent respectively) was lower than those without PEG spacers (121.6mg per ml 
cellulose adsorbent), see Table 2, the average adsorption capacity for LDL-C per ml 
cellulose adsorbent increased from 0.130 mg/ml to 0.903 mg/ml. After the introduction of 
PEG spacers, (see Table 3) and consequently the adsorption capacity for LDL-C per unit 
ligand increased significantly from 0.001 mg/mg L-lysine to 0.105 mg/mg L-lysine, see Table 
4, the adsorption capacity of LDL-C per unit L-lysine ligand (0.027mg LDL-C/mg L-lysine) 
was much higher than that without PEG spacer (0.001mg LDL-C/mg L-lysine). This result 
indicated that in the presence of PEG spacer, the adsorption efficiency of L-lysine ligands 
was enhanced significantly, see Table 5. It is postulated that appropriate increasing the 
amount of the L-lysine ligands and the use of PEG spacers can enhance the adsorption 
capacity for LDL-C. 
 
Molecular weight 
of PEG spacers 
(Da) 
TC LDL-C 
Removal 
capacity (%) 
Removal 
amount 
(mg/ml) 
Removal 
capacity (%) 
Removal 
amount 
(mg/ml) 
1000 11.45±0.35 0.351±0.011 12.01±0.79 0.242±0.017 
2000 14.90±0.69 0.458±0.020 13.04±0.71 0.263±0.013 
4000 28.94±0.33 0.889±0.011 35.13±0.69 0.708±0.017 
6000 33.48±0.33 1.028±0.011 44.76±0.36 0.903±0.003 
Source: Wang S Q et al, Reactive & Functional Polymers (2008), 68: 261-267 
 Adsorption capacity and adsorption percentage of TC, and LDL-C by cellulosic beads with Table 2.
different molecular weight of PEG as a spacer 
 
Mol. weight of 
PEG spacers 
(Da) 
L-Lysine 
amount 
(mg/ml) 
Average removal 
amount of LDL－
C (mg/ml) 
Stoichiometric 
capacity (mg LDL-
C/mg L-lysine) 
Efficiency of 
active site 
(%)* 
1000 10.5 0.242 0.023 22 
2000 9.8 0.263 0.027 26 
4000 9.0 0.708 0.079 75 
6000 8.6 0.903 0.105 100 
Source: Wang S Q et al, Reactive & Functional Polymers (2008), 68: 261-267 
 Adsorption capacity of LDL-C per mg L-lysine Table 3.
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Mol .weight of 
PEG spacers 
(Da) 
L-lysine 
amount 
(mg/ml) 
Average 
removal 
capacity of LDL 
(mg/ml) 
Stoichiometric 
capacity (mg 
LDL/mg L-lysine) 
Efficiency of 
active site (%)* 
— 121.6 0.130±0.013 0.001 1.018±0.098 
1000 10.5 0.242±0.017 0.023 21.947±1.469 
2000 9.8 0.263±0.013 0.027 25.556±1.178 
4000 9.0 0.708±0.017 0.078 74.917±1.549 
6000 8.6 0.903±0.003 0.105 100.000 
Source: Wang S Q et al, Reactive & Functional Polymers (2008), 68: 261-267 
 Adsorption capacity of LDL –C by L-lysine ligand Table 4.
 
 CPS-lysine CPS-PEG1000-lysine 
Adsorption 
capacity(mg/g) 
Adsorption 
percentage (%) 
Adsorption 
capacity(mg/g) 
Adsorption 
percentage (%) 
TC 0.664 8.769 0.402 5.31 
LDL-C 1.493 33.559 4.158 93.29 
TG 0.419 6.213 0.132 1.97 
HDL-C 0.204 15.170 0.341 24.48 
Source: Wang S Q et al, Reactive & Functional Polymers (2008), 68: 261-267 
 Adsorption capacity of TC and LDL by CPS beads with and without PEG as spacer Table 5.
4. Typical bioactive bead type cellulosic adsorbent for blood purification 
4.1. Cellulosic adsorbents for removing low density lipoprotein –cholesterol 
(LDL-C) 
Familial hypercholesterolemia is characterized by a high concentration of plasma cholesterol in 
the form of low-density lipoprotein-cholesterol (LDL-C). In order to decrease the LDL-C level 
in patients, drugs and surgical intervention were reported [35]. Sorbent-perfusion treatment is 
currently employed when the reduction of LDL-C level appears impossible to be achieved by 
drug administration [36-38]. Since the late 1970s, scientists have been engaged in developing 
different kinds of adsorbents to remove pathogenic substances [39-41]. 
Yaoting Yu and Shenqi Wang et al [42,43] have developed cellulosic adsorbent with 
amphiphilic ligands for the adsorption of (LDL-C) which was prepared by the following 
procedure: Cellulose beads were reacted with cholesterol N-(6-isocyanatohexyl) carbamate 
in the presence of pyridine in DMSO at 80℃ in order to introduce the hydrophilic moiety. It 
was then reacted with chlorosulfonic acid in dimethyl formamide to introduce the sulfonic 
group see Figure 6 
The effects of sulfonation and grafting time of cholesterol on the swelling property of 
adsorbent were studied. Results showed that sulfonation and grafting time of cholesterol  
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(From Wang S Q et al, Artif Cells Blood Sub (2002), 30: 285-292, adapted) 
Figure 6. Schematic structure of amphiphilic cellulose adsorbent 
was 3 and 5 h, respectively. The amphiphilic adsorbent had a high adsorption capacity for 
LDL-C without significantly adsorbing high-density lipoprotein. Rabbit model was 
constructed according to the following method [44]. In brief, Japanese white male rabbits 
were purchased from local experimental animal institute and housed in a standard facility. 
After feeding with standard chow and water ad libitum for one week, the healthy rabbits 
were divided into control group (group 1, n=6) and hyperlipidemia group. Rabbits in the 
control group consumed standard chow from 120-150g/d and water ad libitum. In the 
hyperlipidemia model group, the rabbits were fed with standard chow supplemented with 
0.5-1% cholesterol, 15% egg yolk and 5% animal oil. After 8 weeks, the rabbits in the 
hyperlipidemia group were further divided into two groups, that was group No.2 (n=6), 
(without any treatment) and group No.3 (n=6), (treated by sorbent-perfusion.). Experimental 
results showed that the LDL-C levels decreased significantly after 2 h perfusion indicating 
the adsorbent could effectively remove LDL-C, see Table 6. Furthermore, sorbent-perfusion 
also reduced all the subfractions of LDL-C, therefore decreased the risk for the development 
of atherosclerosis and myocardial infarction, see Table 7. 
 
Parameter Before (mmol/l) After (mmol/l) Reduction (%) 
TC 8.54±1.01 3.33±0.63*, 61.20±2.81 
TG 1.845±0.191 1.05±0.153*, 43.09±2.43 
LDL-C 3.619±0.354 0.724±0.07*, 78.56±0.147 
HDL-C 0.216±0.06 0.205±0.057 5.09±0.042 
Note: n=6, 
Source: Wang S Q et al, Biomaterials (2003), 24: 2189-2194 
 Removal of lipoproteins by amphiphilic adsorbent Table 6.
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 Before perfusion After perfusion Change=(A-B)
mmol/l % mmol/l % 
LDL-1 0.51±0.061 13.95±2.1* 0.12±0.046 15.1±2.3 8.24±2.6 
LDL-2 1.65±0.019 45.4±5.3* 0.38±0.043 53.4±5.8* 17.36±3.4 
LDL-3 1.45±0.052 40.1±4.7* 0.23±0.024 31.6±3.6* -21.20±3.9 
Note: n=6 
Source: Wang S Q et al, Biomaterials (2003), 24: 2189-2194 
 Removal of LDL-C subfraction by amphiphilic adsorbent Table 7.
The authors also developed the adsorbent with lysine and phosphate groups as ligand for 
the treatment of hyperlipidemia [34, 45]. Comparing to the amphiphilic adsorbent, the 
adsorbent with lysine as ligand has a lower adsorption capacity for LDL-C, total cholesterol 
and higher HDL-C. On the other hand, the phosphalated cellulosic adsorbent has a higher 
adsorption capacity for LDL-C and lower for HDL-C, see Table 8. 
 
Sample 1 2 3 4 
Amount of coupled phosphate(μmol/ml) 0 68.4 94.3 128.6 
Adsorption 
capacity 
(mg/ml) 
TC 0.893 0.735 0.939 1.586 
LDL 1.235 1.515 1.707 2.721 
HDL 0.134 0.039 0.058 0.063 
Source: Wang T et al, Chinese Journal of Biomedical Engineering ( 2008), 27: 132-136 
 Effect of amount of coupled phosphate on adsorption capacity Table 8.
Haofeng Yu et al [46] synthesized PAA-grafted cellulosic adsorbent for the removal of LDL-
C from human plasma. In-vitro studies showed that this adsorbent could remove total 
cholesterol (TC), LDL-C, and triglyceride (TG) at levels of 5.55, 4.46, and 2.48 mg /m1 
respectively. Unfortunately, it removed 30% HDL-C in the plasma. 
4.2. Cellulosic adsorbents for removal of rheumatoid factors 
Rheumatoid Arthritis (RA) is a rather wide-spread immune disease. Spector reported that 
there is about 1% of the world's population is infected by this disease. Lianyong Wang and 
Yaoting Yu et al [25] covalently linked ss-DNA to cellulosic beads for the removal of 
rheumatoid factors. In vitro and in vivo studies showed that the adsorbent had a high 
adsorption capacity for IgMRF, IgGRF and IgARF, see Figure 7. Furthermore, the adsorbent 
attained good blood compatible properties.  
Sorbent-perfusion using the above mentioned adsorbent was conducted on 35 RA patients 
clinically. Clinical protocol was designed as follows: 46 patients were hospitalized from Dec. 
1998 until Nov.2000 and diagnosed as RA sickness. The extent of joint pain, swelling, 
morning stiffness, nodules under the skin, titer of rheumatoid arthritis factor (RF), value of 
immune-globulin and X-ray diagnosis of sick ankle etc. were all performed. The patients 
were divided into several groups from the above 46 patients. 35 of them matched the 
American Rheumatoid Arthritis Standard of 1987[47].  
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Note:IU is abbreviation of international unit  
(Source: Wang L Y et al, Chemical Research in Chinese Universities(2004),20: 795-800) 
Figure 7. Adsorption capacity versus amount of DNA immobilized 
RA patients were graded into 4 grades according to the functional ability of the sick joint. 
11cases having grade II joint sickness, 20 cases having grade III and 1 case having gradeIV. 
Conventional method of treatment was performed on 30 cases. The control group compared 
to treated group with a significance of P>0.05. 
After perfusion the levels of rheumatoid factor was reduced and platelet count showed no 
significant changes in 35 RA patients (P<0.05) during treatment. After one week joint pain, 
swelling, tenderness, morning stiffness disappeared in 90 percent patients; 80 percent 
abnormal indexes recovered to normal value. After two to three weeks, joint function of 82 
percent patients were improved and reached grade II or I. Two to three months later, X-ray 
examinations showed 80 percent bone matrix destruction was restored. Results of follow-up 
(0.67-2.5 years) proved that effective rate (97.14%, 81.25%) and total remission rate (82.86%, 
59.38%) all had a significant improvement and recovery when compared to routine therapy.  
In conclusion, clinical results show that sorbent-perfusion by cellulosic adsorbents is an 
effective approach for the therapy of rheumatoid arthritis. The treatment is safe, without 
hemolysis or pyrogenic side reactions, the adsorbent is easy to sterilize and cost effective. 
4.3. Cellulosic adsorbents for removal of endotoxin  
Bacterial endotoxins (ET), frequently named as lipopolysaccharides (LPS), are components 
of the outer cell wall of gram-negative bacteria and supposed to be a key factor in the 
pathogenesis of endotoxemia and septic shock [48,49] . Sorbent-perfusion is one of the best 
methods to remove endotoxin. Hui Fang and Yaoting Yu et al [10] synthesized a new type 
adsorbent for the removal of bacterial endotoxins by immobilizing lysine covalently onto 
cellulosic beads. Results showed that the adsorbent has good biocompatibility, see Table 9. 
In order to evaluate the adsorbent’s properties, rabbit models were constructed by the 
following method [10]: Thirteen New Zealand white rabbits (weight 2.0-2.5 Kg) were 
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injected intravenously with 0.20 mg LPS (E.coli O55: B5, sigma) to induce endotoxemia after 
being anaesthetized. The rabbits were classified into two groups, one was the treated group 
(n=8) perfused through adsorbents while the other was the control group (n=5) without 
undergoing perfusion. Sorbent-perfusion was conducted 1.5 hours after LPS administration 
and conventional equipments for perfusion were used. Blood was drawn from the artery 
and returned to the vein by peristaltic pump (Pharmacia-LKB). The perfusion was carried 
out at a rate of 5 ml/min for 2 hours and the adsorbent showed a strong ET-binding capacity. 
After perfusion, the blood ET level was decreased from 5.56±0.54 EU/ml to 0.41±0.26 EU/ml, 
see Figure 8. Liver function and renal function tests as well as SOD, malondialdehyde 
(MDA) assays were conducted. Results all showed that the septic symptoms were 
ameliorated with the removal of large amounts of ET in the blood which obviously 
prevented further damage to the organs, see Table 10, Figure 9 and 10. 
 
Note: EU is the abbreviation of Endotoxin unit, which is used to indicate the content of endotoxin (From Fang H and 
Yu Y T,et al, Biomaterials(2004), 25: 5433-5440) 
Figure 8. Removal of ET from rabbit’s blood by perfusion  using Lys immobilized cellulosic beads 
 
Parameters tested Results 
Hemolysis 1.1% (standard <5% ),(n=3) 
Platelet adhesion 18.76% (n=3) (10% is excellent; 10-30% is good) 
Whole body toxicology 
Wt. of rat before test Wt. of rat after test 
21.50.61 (g) 24.42.04 (g) (n=5) 
Allergic reaction 
Grade 1, not higher than negative control (n=10), 
none allergic 
Cytotoxicology R* index of sample=0/0 (n=6), none toxic 
Skin stimulation PII**=0.0-0.4, (N=15), very mild toxic 
R* index of sample=R index of extract – R index of sample tested=0.5/0- 0.5/0=0/0, PII** is the skin stimulation index 
Note: The biocompatibility and toxicology tests of the adsorbent were conducted by the Testing and Evaluation 
Research Centre of Biomedical Materials in Tianjin, China according to the Criteria of GB/T16886.5-1997 in correlation 
to ISO 10993.4:2002, Source: Fang H and Yu Y T et al, Biomaterials (2004), 25: 5433-5440 
 Biocompatibility and toxicology properties of the adsorbent Table 9.
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Parameter Groups 0 min 60 min  120 min 
SA 
(g/L) 
Perfusion 26.7±2.4 24.5±1.8 23.2±2.3 
Control 26.1±3.7 22.0±2.2 24.1±4.6 
TBL 
(mg/ml) 
Perfusion 0.04±0.01 0.05±0.02 0.05±0.01 
Control 0.05±0.01 0.08±0.03 0.09±0.02 
AST 
(U/L) 
Perfusion 15.3±4.0 12.1±3.2 14.0±4.2 
Control 17.9±5.7 27.6±6.9 35.7±8.0 
ALT 
(U/L) 
Perfusion 34.4±9.5 25.9±9.1 24.8±8.5 
Control 35.3±9.9 34.5±6.2 41.4±1.8 
AKP 
(U/L) 
Perfusion 113.1±8.5 116.9±19.2 118.1±25.7 
Control 109.4±10.3 153.0±17.3 195.5±31.2 
BUN 
(mmol/L) 
Perfusion 5.2±0.6 4.9±1.3 4.6±0.6 
Control 5.6±1.1 7.3±0.8 7.8±0.7 
CRK 
(umol/L) 
Perfusion 61.8±4.8 59.3±7.5 70.9±2.0 
Control 62.7±4.2 80.4±3.7 94.3±4.7 
 Note: n=3 
Source: Fang H and Yu Y T ,et al, Biomaterials (2004), 25: 5433-5440 
 Liver and renal function tests Table 10.
 
 
 
 
 
 
 
 
Note: the NU is a unit that is used to indicate the activity of SOD, (From Fang H and Yu Y T et al, Biomaterials (2004), 
25: 5433-5440) 
Figure 9. Improved activities of serum superoxide dismutase (SOD) versus ET removal by perfusion 
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(From Fang H and Yu Y T et al, Biomaterials (2004), 25: 5433-5440) 
Figure 10. Decrease in malondialdehyde (MDA) concentrations versus ET removal by perfusion 
4.4. Cellulosic adsorbents for removal of anti-DNA antibody in treatment of 
systematic lupus erythematosus  
The abnormally high levels of anti-DNA antibodies and immune complex in the sera of 
systemic lupus erythematosus (SLE) patients can be removed by sorbent- perfusion. Yaoting 
Yu and Deling Kong [50] synthesized cellulose adsorbents with DNA as ligand for the 
removal of anti-DNA antibodies. The activation of cellulosic beads were conducted 
according to reference [50]: In brief, 2 ml of activated cellulose beads was added to 4.0ml 
buffer solution containing 4.0mg DNA in a flask and stirred at 25℃ for 20 h on a shaker. 
Then the immobilized DNA beads were washed consecutively with buffer solution and 
water, until no leakage of DNA in the rinse water was detected at 260nm by UV 
spectrometer. The immunoadsorbent thus obtained was stored at 4℃. In vitro adsorption 
tests showed that the DNA immuno-adsorbent could remove 40%-70% of anti-DNA 
antibody from plasma [29]. The maximum decrease of anti-DNA level was 80% after 60 min 
in a dynamic experiment. This high adsorption capacity shows a high potential for clinical 
application. 
4.5. Cellulosic adsorbent for the treatment of myasthenia gravis  
Myasthenia gravis (MG) is an autoimmune disorder characterized by a disturbance in 
neuromuscular transmission that results in muscle weakness. Yaoting Yu and Li Yang et al 
[51, 52] synthesized immobilized tryptophan cellulosic adsorbent and evaluated its 
adsorption capacity for binding acetylcholine receptor in the plasma of MG patients. 
Experimental autoimmune myasthenia gravis (EAMG) rabbits were induced by Ta183-200 
peptide according to the following method: Briefly, Female rabbits weighing approximately 
2 kg were injected intradermally at multiple sites with 500μg of Ta183-200, which was 
emulsified with an equal volume of Freund’s complete adjuvant. A booster injection of 500 
μg Ta183-200 with Freund’s incomplete adjuvant was administered after 4 weeks. 
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The rabbits underwent extracorporeal whole blood perfusion for 2 h. Results showed no 
significant damages on blood cells and changes in the concentration of electrolytes. Whole 
blood sorbent-adsorption improved clinical manifestation and neuromuscular function of 
the EAMG rabbits, see Table 11 
 
No. of rabbits Pre WBIA 5th day after WBIA 
1 + 0 - + 
2 + 0 
3 + 0 
4 + 0 
5 + 0 
6 + 0 
7 ++ + 
8 + 0 
Note： 0 stands for the rabbits recovered normally after therapy 
Source: Yang L et al, Artif Cell Blood Sub(2004), 32: 519-528 
 Grading of clinical manifestation pre and 5th day after WBIATable 11.  
The neuromuscular transmission function was evaluated by the stimulation of the deep 
peroneal nerve. The mean decrement of potentials evoked from the anterior tibial muscle, at 
three stimulation frequencies in the therapeutic rabbit group were determined. At 3Hz, the 
potential decreased from 21.87% to 17.87%, at 5Hz, decreased from 22.25% to 18.75% and at 
10 Hz, decreased from 24.37% to 23.25%. Table 12 shows the changes of the electro-
physiological features of EAMG rabbits after WBIA which was on the 5th (D5) and the 8th 
(D8) day after passive transfer. The same RNS was performed in the control rabbit group, 
but no decrement was found, see Table 12 
 
Frequency Therapeutic group (%)  Control group (%) 
 D5 D8 D5 D8 
3Hz 21.875±3.226 17.875±1.642 21.375±2.615 21.125±2.416 
5Hz 22.250±2.815 18.750±1.388 21.875±2.232 22.000±1.772 
10Hz 24.375±1.685 23.250±1.388 23.875±1.126 24.125±2.696 
Source: Yang L et al, Artif Cell Blood Sub(2004), 32: 519-528 
 Comparison of the decrement of RNS between the therapeutic and the control group Table 12.
The quantity of neuromuscular junction can reflect the neurotransmission function. On the 
3rd day after WBIA (D8), the quantity of neuromuscular junction per unit area (25mm2) of 
the therapeutic rabbit group was determined. Figure 11 shows the quantity of 
neuromuscular junction per unit area increased from 9.8253.401 to 10.902.879(P<0.05) after 
WBIA, which was higher than that of the control group (P<0.01)  
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NOTE: a and b stand for the results before and after WBIA 
(From Li X H et al, Artif. Cell Blood Sub (2010), 38:186-191) 
Figure 11. Neuromuscular junctions of the therapeutic rabbit group before and after WBIA on the 3rd 
day（200） 
In conclusion, extracorporeal whole blood sorbent-adsorption is an effective and safe 
approach in treating the passive experimental autoimmune myasthenia gravis by improving 
clinical manifestation, neuromuscular transmission function, enhancing the quantity of 
neuromuscular junction and antibody titer.  
5. Conclusion and future perspectives 
Intensive research and development of cellulosic bead type adsorbents by sorbent-perfusion 
in blood purification have paved a path for the treatment of patients with autoimmune 
diseases, hyperlipidemia and inflammatory disorders. Animal experiments and clinical 
trials have proved that it is safe, efficient and cost effective. Therefore, it is highly potential 
to be used clinically on patients for upgrading the quality of their living standard and 
prolonging their survival rates. 
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